Fresenius Kidney Care:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fresenius Kidney Care - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3464
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fresenius Kidney Care (FMCNA), formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical information system, bloodlines and concentrates, home therapy products and others; its home therapy products include peritoneal dialysis products and home hemodialysis products. FMCNA offers services such as patient care, laboratory services, customer and technical support, courier services, education and training, managed care, billing, physician services, inpatient services and research services. The company also offers recopies for breakfasts, lunches, dinners, snacks and beverages. It has operations in Utah and California. FMCNA is headquartered in Waltham, Massachusetts, the US.

Fresenius Kidney Care – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kidney Care, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kidney Care, Medical Devices Deals, 2012 to YTD 2018 9
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 11
Partnerships 12
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 12
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 13
Asset Transactions 14
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 14
Fresenius Kidney Care – Key Competitors 15
Fresenius Kidney Care – Key Employees 16
Fresenius Kidney Care – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Legal and Regulatory 18
Jan 07, 2017: Statement of Fresenius Medical Care Regarding Lawsuit Challenging Premium Assistance Regulation 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Key Facts 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kidney Care, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kidney Care, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kidney Care, Medical Devices Deals, 2012 to YTD 2018 9
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 11
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 12
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 13
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 14
Fresenius Kidney Care, Key Competitors 15
Fresenius Kidney Care, Key Employees 16

List of Figures
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kidney Care, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Fresenius Kidney Care:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saxo Bank A/S:企業のM&A・事業提携・投資動向
    Saxo Bank A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Saxo Bank A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Kopitiam Investment Pte Ltd:企業の戦略・SWOT・財務分析
    Kopitiam Investment Pte Ltd - Strategy, SWOT and Corporate Finance Report Summary Kopitiam Investment Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Imaging Dynamics Company Ltd (IDL)-医療機器分野:企業M&A・提携分析
    Summary Imaging Dynamics Company Ltd (IDC) is a medical technology company that offers solutions in medical imaging and digital radiography technology. The company provides flat panel technology, CCD technology, 2200 X-series, 1600 Plus X-series, 1600 X-series, 1590 X-series, image processing softwa …
  • HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • L’Occitane International SA:企業の戦略・SWOT・財務分析
    L'Occitane International SA - Strategy, SWOT and Corporate Finance Report Summary L'Occitane International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BioVectra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioVectra Inc (BioVectra), a subsidiary of Mallinckrodt Plc, is a contract development and manufacturing organization that offers cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients. The organization's products include bioprocessing reagents, diagnostic reagent …
  • Kiewit Corp:企業の戦略的SWOT分析
    Kiewit Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Navamedic ASA (NAVA):医療機器:M&Aディール及び事業提携情報
    Summary Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. …
  • Toray Industries Inc (3402):製薬・医療:M&Aディール及び事業提携情報
    Summary Toray Industries Inc (Toray) is a provider of advanced materials. The company's product portfolio includes fibers, fashion apparel, plastics, chemicals, IT-related products, composite materials, life sciences products, and medical devices, pharmaceuticals, and optical products. It provides i …
  • InVivoScribe Technologies Inc:企業の製品パイプライン分析
    Summary InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company offer full range of hematology-oncology testing products and services. It’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent de …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • IDInvest Partners:企業のM&A・事業提携・投資動向
    IDInvest Partners - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IDInvest Partners Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Islet Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Brambles Limited (BXB):企業の財務・戦略的SWOT分析
    Brambles Limited (BXB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ipsen SA (IPN):企業の財務・戦略的SWOT分析
    Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Aptiv Plc. (APTV):企業の財務・戦略的SWOT分析
    Aptiv Plc. (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Qioptiq Group:企業の戦略的SWOT分析
    Qioptiq Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆